FORMA THERAPEUTICS HOLDINGS, INC. Increase (Decrease) in Accounts Payable
FORMA THERAPEUTICS HOLDINGS, INC. reported Increase (Decrease) in Accounts Payable of -$1.08 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2022-08-05
- FORMA THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2022-06-30 was $1.06M, a 49.45% decline year-over-year.
- FORMA THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2022-03-31 was -$2.14M.
- FORMA THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2021-12-31 was -$445.00K, a 176.99% decline year-over-year.
- FORMA THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2021-09-30 was -$449.00K, a 1762.96% decline year-over-year.
- FORMA THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2021 was -$173.00K, a 118.54% decline from fiscal 2020.
- FORMA THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2020 was $933.00K.
- FORMA THERAPEUTICS HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2019 was -$2.78M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2022-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$1.08M 10-Q · filed 2022-08-05 | -$1.53M derived: sum of 3 quarters · filed 2022-08-05 | -$1.98M derived: sum of 4 quarters · filed 2022-08-05 |
| 2022-03-31 | -$2.14M 10-Q · filed 2022-05-06 | -$2.58M derived: sum of 2 quarters · filed 2022-05-06 | -$3.03M derived: sum of 3 quarters · filed 2022-05-06 | -$943.00K derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-12-31 | -$445.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$894.00K derived: sum of 2 quarters · filed 2022-03-01 | $1.20M derived: sum of 3 quarters · filed 2022-08-05 | -$173.00K 10-K · filed 2022-03-01 |
| 2021-09-30 | -$449.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.64M derived: sum of 2 quarters · filed 2022-08-05 | $272.00K 10-Q · filed 2021-11-12 | $850.00K derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-06-30 | $2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $721.00K 10-Q · filed 2022-08-05 | $1.30M derived: sum of 3 quarters · filed 2022-08-05 | $1.33M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | -$1.37M 10-Q · filed 2022-05-06 | -$790.00K derived: sum of 2 quarters · filed 2022-05-06 | -$763.00K derived: sum of 3 quarters · filed 2022-05-06 | $985.00K derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | $578.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $605.00K derived: sum of 2 quarters · filed 2022-03-01 | $2.35M derived: sum of 3 quarters · filed 2022-03-01 | $933.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.77M derived: sum of 2 quarters · filed 2021-11-12 | $355.00K 10-Q · filed 2021-11-12 | $1.07M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $328.00K 10-Q · filed 2021-08-13 | $1.05M derived: sum of 3 quarters · filed 2021-08-13 | $808.00K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | -$1.42M 10-Q · filed 2021-05-14 | -$702.00K derived: sum of 2 quarters · filed 2021-05-14 | -$940.00K derived: sum of 3 quarters · filed 2021-05-14 | |
| 2019-12-31 | $718.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $480.00K derived: sum of 2 quarters · filed 2021-03-30 | -$2.78M 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$238.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$3.50M 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | -$3.26M 10-Q · filed 2020-08-13 |